Valacyclovir versus valganciclovir for cytomegalovirus prophylaxis in kidney transplant recipients: a systematic review and comparative meta-analysis

Valacyclovir versus valganciclovir for cytomegalovirus prophylaxis in kidney transplant recipients: a systematic review and comparative meta-analysis

Background : Valganciclovir (ValG) is the most widely used drug for cytomegalovirus (CMV) prophylaxis in kidney transplant recipients (KTRs). However, it is associated with dose-limiting side effects and considerable costs. Some centers have identified valacyclovir (ValA) as an economically attracti...

Full description

Saved in:
Bibliographic Details
Main Authors: Leonardo Januário Campos Cardoso, Kleuber Arias Meireles Martins, Paulo Vitor Marques, Ivan Petterson Santana Teixeira, Ester Magalhães, Juan Lima Minkauskas, Isabela Coutinho Faria, Filipe Melo Ribeiro
Format: Article
Language:English
Published: The Korean Society for Transplantation 2025-03-01
Series:Clinical Transplantation and Research
Subjects:
kidney
valganciclovir
valacyclovir
cytomegalovirus
Online Access:https://www.ctrjournal.org/journal/view.html?doi=10.4285/ctr.24.0034
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.ctrjournal.org/journal/view.html?doi=10.4285/ctr.24.0034

Similar Items